Quarterly Results

  • Company Name :
Gufic BioSciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 509079
  • NSE Symbol:
  • GUFICBIO
  • P/E(TTM):
  • 60.39
  • ISIN Demat:
  • INE742B01025
  • Div & Yield%:
  • 0.03
  • EPS(TTM):
  • 6.10
  • Book Value(₹):
  • 59.97
  • Market Cap(₹Cr.):
  • 3,694.22
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars June 2025 ( Cr)March 2025 ( Cr)December 2024 ( Cr)
Gross Sales 226.91 205.02 207.79
Excise Duty 0.00 0.00 0.00
Net Sales 226.91 205.02 207.79
Other Operating Income 0.00 0.00 0.00
Other Income 0.89 0.38 1.86
Total Income 227.81 205.40 209.66
Total Expenditure 194.58 178.38 173.85
PBIDT 33.23 27.02 35.81
Interest 9.23 8.40 4.91
PBDT 24.00 18.62 30.90
Depreciation 7.72 7.84 4.62
Tax 2.22 0.29 3.95
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 1.98 2.51 3.01
Reported Profit After Tax 12.07 7.97 19.32
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 12.07 7.97 19.32
EPS (Unit Curr.) 1.20 0.80 1.93
EPS (Adj) (Unit Curr.) 1.20 0.80 1.93
Calculated EPS (Unit Curr.) 1.20 0.80 1.93
Calculated EPS (Adj) (Unit Curr.) 1.20 0.80 1.93
Calculated EPS (Ann.) (Unit Curr.) 4.82 3.18 7.71
Calculated EPS (Adj) (Ann.) (Unit Curr.) 4.82 3.18 7.71
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.03 10.03 10.03
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 14.64 13.18 17.23
PBDTM(%) 10.58 9.08 14.87
PATM(%) 5.32 3.89 9.30